2168 related articles for article (PubMed ID: 8348939)
1. In vitro inhibition of interleukin-2-induced defective polymorphonuclear chemotaxis by TNF inhibitor.
Fossat C; Sainty D; Stoppa AM; Blaise D; David M; Maraninchi D; Juhan-Vague I
Eur J Haematol; 1993 Jul; 51(1):13-7. PubMed ID: 8348939
[TBL] [Abstract][Full Text] [Related]
2. Pentoxifylline in vitro reverses neutrophil chemotactic deficiency induced by interleukin-2 treatment.
Fossat C; Sainty D; Stoppa AM; Maraninchi D; Juhan-Vague I
Nouv Rev Fr Hematol (1978); 1992; 34 Suppl():S61-4. PubMed ID: 1340531
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-2 induces chemotactic deficiency in patients with onco hematologic malignancies and autologous bone marrow transplantation.
Stoppa AM; Fossat C; Blaise D; Viens P; Brandely M; Pourreau CN; Sainty D; Novakovitch G; Miquel M; Juhan-Vague I
Eur Cytokine Netw; 1991; 2(4):231-7. PubMed ID: 1661618
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha decreases neutrophil chemotaxis to N-formyl-1-methionyl-1-leucyl-1-phenylalanine: analysis of single cell movement.
Vollmer KL; Alberts JS; Carper HT; Mandell GL
J Leukoc Biol; 1992 Dec; 52(6):630-6. PubMed ID: 1464735
[TBL] [Abstract][Full Text] [Related]
5. Role of cytokines in the modulation of neutrophil chemotaxis in localized juvenile periodontitis.
Agarwal S; Suzuki JB; Riccelli AE
J Periodontal Res; 1994 Mar; 29(2):127-37. PubMed ID: 8158501
[TBL] [Abstract][Full Text] [Related]
6. Failure of neutrophil chemotactic function in breast cancer patients treated with chemotherapy.
Mendonça MA; Cunha FQ; Murta EF; Tavares-Murta BM
Cancer Chemother Pharmacol; 2006 May; 57(5):663-70. PubMed ID: 16133528
[TBL] [Abstract][Full Text] [Related]
7. Potential role of IL-8, platelet-activating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis.
Drost EM; MacNee W
Eur J Immunol; 2002 Feb; 32(2):393-403. PubMed ID: 11813158
[TBL] [Abstract][Full Text] [Related]
8. Effect of recombinant human interleukin-2 on the chemotaxis and chemiluminescence of human polymorphonuclear leukocytes.
Sugiyama H; Ono Y; Kunii O
Kansenshogaku Zasshi; 1993 Dec; 67(12):1178-82. PubMed ID: 8294767
[TBL] [Abstract][Full Text] [Related]
9. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
Kew RR; Grimaldi CM; Furie MB; Fleit HB
J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
[TBL] [Abstract][Full Text] [Related]
10. Fibrin regulates neutrophil migration in response to interleukin 8, leukotriene B4, tumor necrosis factor, and formyl-methionyl-leucyl-phenylalanine.
Loike JD; el Khoury J; Cao L; Richards CP; Rascoff H; Mandeville JT; Maxfield FR; Silverstein SC
J Exp Med; 1995 May; 181(5):1763-72. PubMed ID: 7722453
[TBL] [Abstract][Full Text] [Related]
11. Alpha-defensin 1 (human neutrophil protein 1) as an antichemotactic agent for human polymorphonuclear leukocytes.
Grutkoski PS; Graeber CT; Lim YP; Ayala A; Simms HH
Antimicrob Agents Chemother; 2003 Aug; 47(8):2666-8. PubMed ID: 12878538
[TBL] [Abstract][Full Text] [Related]
12. Aprotinin reduces interleukin-8 production and lung neutrophil accumulation after cardiopulmonary bypass.
Hill GE; Pohorecki R; Alonso A; Rennard SI; Robbins RA
Anesth Analg; 1996 Oct; 83(4):696-700. PubMed ID: 8831305
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-enhanced leukotriene B4 generation and chemotaxis in human neutrophils.
Meyer JD; Yurt RW; Duhaney R; Hesse DG; Tracey KJ; Fong YM; Verma M; Shires GT; Dineen P; Lowry SF
Arch Surg; 1988 Dec; 123(12):1454-8. PubMed ID: 2847685
[TBL] [Abstract][Full Text] [Related]
14. Increased neutrophil migration in smokers with or without chronic obstructive pulmonary disease.
Blidberg K; Palmberg L; Dahlén B; Lantz AS; Larsson K
Respirology; 2012 Jul; 17(5):854-60. PubMed ID: 22509802
[TBL] [Abstract][Full Text] [Related]
15. PMN cells from chronic myeloid leukemia (CML) patients show defective chemotaxis in remission.
Naik NR; Advani SH; Bhisey AN
Leuk Res; 1989; 13(11):959-65. PubMed ID: 2607777
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of neutrophil migration soon after initiation of treatment with leflunomide or methotrexate in patients with rheumatoid arthritis: findings in a prospective, randomized, double-blind clinical trial in fifteen patients.
Kraan MC; de Koster BM; Elferink JG; Post WJ; Breedveld FC; Tak PP
Arthritis Rheum; 2000 Jul; 43(7):1488-95. PubMed ID: 10902750
[TBL] [Abstract][Full Text] [Related]
17. The control of neutrophil chemotaxis by inhibitors of cathepsin G and chymotrypsin.
Lomas DA; Stone SR; Llewellyn-Jones C; Keogan MT; Wang ZM; Rubin H; Carrell RW; Stockley RA
J Biol Chem; 1995 Oct; 270(40):23437-43. PubMed ID: 7559504
[TBL] [Abstract][Full Text] [Related]
18. The protein kinase C inhibitor AEB071 (sotrastaurin) modulates migration and superoxide anion production by human neutrophils in vitro.
Capsoni F; Ongari AM; Reali E; Bosè F; Altomare GF
Int J Immunopathol Pharmacol; 2012; 25(3):617-26. PubMed ID: 23058012
[TBL] [Abstract][Full Text] [Related]
19. Random migration of polymorphonuclear leukocytes induced by GM-CSF involving a signal transduction pathway different from that of fMLP.
Harakawa N; Sasada M; Maeda A; Asagoe K; Nohgawa M; Takano K; Matsuda Y; Yamamoto K; Okuma M
J Leukoc Biol; 1997 Apr; 61(4):500-6. PubMed ID: 9103237
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human tumor necrosis factor alpha lacks chemotactic activity for human peripheral blood neutrophils and monocytes.
Mrowietz U; Schröder JM; Christophers E
Biochem Biophys Res Commun; 1988 Jun; 153(3):1223-8. PubMed ID: 3390181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
